• Managing Diabetic Macular Edema in Clinical Practice
    Oct 2 2025

    The experts discuss strategies, new-generation anti-vascular endothelial growth factors (VEGFs), and the evidence that supports their use.

    Credit available for this activity expires: 9/30/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002951?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    34 mins
  • Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers
    Sep 23 2025

    Are you aware that programmed cell death-ligand 1 (PD-L1) testing may not be needed to guide immunotherapy decisions in resectable gastric/gastroesophageal junction (GEJ) cancers?

    Credit available for this activity expires: 9/22/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002919?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    37 mins
  • Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice
    Sep 19 2025

    Are you up to date on new treatment options for thyroid eye disease?

    Credit available for this activity expires: 9/17/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002870?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    29 mins
  • Immunopathogenesis of IgAN and the Evolving Treatment Landscape: A Focus on the B-Cell Pathway
    Sep 18 2025

    Discover how emerging B-cell-targeted therapies are transforming the treatment landscape and outcomes for patients with IgA nephropathy (IgAN).

    Credit available for this activity expires: 9/18/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002833?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    37 mins
  • Targeted Therapies for NSCLC: Where Are We Today?
    Sep 11 2025

    Are you up to date with therapy strategies for ALK translocation and EGFR mutation–positive non-small cell lung cancer?

    Credit available for this activity expires: 9/10/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002896?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    38 mins
  • Advances in the Pharmacologic Management of Obesity: Looking Ahead to EASD 2025
    Sep 9 2025

    Do you know the latest in obesity management?

    Credit available for this activity expires: 9/5/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002891?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    21 mins
  • Squamous Cell Anal Carcinoma: Bridging Current Practice and Future Horizons With Immunotherapy
    Sep 4 2025

    Do you know where immunotherapy fits in the treatment paradigm of squamous cell anal carcinoma?

    Credit available for this activity expires: 9/3/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002850?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    33 mins
  • Epilepsy Undertreatment and Overtreatment: How Can We Strike a Balance?
    Sep 3 2025

    The power to change lives and save lives: expert advice on how to recognize where action needs to be taken and what to do.

    Credit available for this activity expires: 9/2/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002731?ecd=bdc_podcast_libsyn_mscpedu

    Show More Show Less
    34 mins